Transplantation and Cellular Therapy Meetings
Oncology Nurses Drastically Reduce Central Line Infection Incidences Through Peer-to-Peer Observation Strategy
May 11, 2022
Article
Oncology nurses at the 2022 ASTCT Meeting shared how a peer-to-peer observation and validation tool helped decrease central line-associated bloodstream infections by 68%.
Liso-cel Exhibits Durable Responses in Relapsed-Refractory Large B-Cell Lymphoma
April 27, 2022
Article
Patients with relapsed/refractory large B-cell lymphoma continued to derive benefit from lisocabtagene maraleucel after 2 years of follow-up.
Axi-cel Sustains Long-Term Survival Rates in Relapsed/Refractory Large B-Cell Lymphoma
April 26, 2022
Article
Patients with relapsed or refractory large B-cell lymphoma experienced improved overall survival following treatment with axicabtagene ciloleucel.
Belimumab May Help Prevent Chronic GVHD in Adults Undergoing Allogenic Transplant
April 26, 2022
Article
Belimumab has emerged as a safe and tolerable agent that may be useful for the prophylaxis of chronic graft-vs-host-disease.
Advertisement
Advertisement